================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13D-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13D-1(B), (C), AND (D) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13D-2(B)
(AMENDMENT NO. 12)(1)
Boston Scientific Corporation
-------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value per share
-------------------------------------------------------
(Title or Class of Securities)
101137 10 7
-------------------------------------------------------
(CUSIP Number)
December 31, 2004
-------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[_] Rule 13d-1(c)
[X] Rule 13d-1(d)
________________________
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
================================================================================
===================== ===========
CUSIP NO. 101137 10 7 13G PAGE 2 OF 5
===================== ===========
================================================================================
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
John E. Abele
------- ------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
Not applicable. (b) [_]
------- ------------------------------------------------------------------------
3 SEC USE ONLY
------- ------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The United States of America
------- ------------------------------------------------------------------------
5 SOLE VOTING POWER
54,444,500(See Item 4(a))
NUMBER OF ------- -----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 4,174,238
EACH ------- -----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 54,444,500 (See Item 4(a))
------- -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
4,174,238
------- ------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
58,618,738
------- ------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[X]
------- ------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.5%
------- ------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
===================== ===========
CUSIP NO. 101137 10 7 13G PAGE 3 OF 5
===================== ===========
ITEM 1(A). NAME OF ISSUER:
Boston Scientific Corporation, a Delaware corporation
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
One Boston Scientific Place
Natick, MA 01760
ITEM 2(A). NAME OF PERSON FILING:
John E. Abele (the "Reporting Person")
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
c/o Boston Scientific Corporation
One Boston Scientific Place
Natick, MA 01760
ITEM 2(C). CITIZENSHIP:
The United States of America
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock, $0.01 par value per share
ITEM 2(E). CUSIP NUMBER:
101137 10 7
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B),
CHECK WHETHER THE PERSON FILING IS A:
Not applicable.
ITEM 4. OWNERSHIP: (3)
(a) Amount beneficially owned: The Reporting Person owns
beneficially a total of 58,618,738(2) shares.
(b) Percent of class: 6.9%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 54,444,500
(ii) Shared power to vote or to direct the vote: 4,174,238
(iii) Sole power to dispose or to direct the disposition of:
54,444,500
(iv) Shared power to dispose or to direct the disposition of:
4,174,238
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
Not applicable.
===================== ===========
CUSIP NO. 101137 10 7 13G PAGE 4 OF 5
===================== ===========
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
Not applicable.
ITEM 10. CERTIFICATIONS:
Not applicable.
______________________
(2) Includes 3,812,800 shares owned by a charitable trust of which the
Reporting Person is a trustee and shares investment and ownership control and
361,438 shares owned by a trust of which the Reporting Person shares investment
and ownership control. Also includes 181,000 shares subject to exercisable
options granted to the Reporting Person. Does not include 400,000 shares owned
by the Reporting Person's wife. In accordance with Rule 13d-4, the Reporting
Person disclaims beneficial ownership of these 400,000 shares.
===================== ===========
CUSIP NO. 101137 10 7 13G PAGE 5 OF 5
===================== ===========
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 14, 2005
-------------------------
(Date)
/s/ John E. Abele
--------------------------
John E. Abele